ResveraGranate
Natural health product licensed in Canada
- Licence holder
- Sensation Therapy
- NPN or DIN-HM
- 80067936
- Status
- Active licence
- Licence date
- 23 March 2016
- Revision date
- 26 September 2016
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Euterpe oleracea Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 milligramme | 100 milligramme | Not calculated |
| trans-Resvératrol Source : Reynoutria Japonica - racine | 300 milligramme | Not calculated |
| Punica granatum Source : Punica granatum - Graine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 milligramme | 25 milligramme | Not calculated |
| Vitis vinifera Source : Fruit Extract : Matériel brut sec Extraction ratio : 200:1 Dry plant equivalent : 2,500 milligramme Potency : 30 Pour cent Poly(phénols) | 12.5 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Fournit des antioxydants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Si vous êtes enceinte ou allaitez, consulter un praticien de soins de santé avant d'en faire l'usage. ¿Si vous prenez des médicaments d'ordonnance, consulter un praticien de soins de santé avant d'en faire l'usage puisque le resvératrol pourrait altérer l'efficacité de ces médicaments.
- Effets indésirables connus
Une hypersensibilité/allergie peut se manifester lors de la consommation de l'açaï ou aux plantes de la famille des Arecaceae. Si tel est le cas, cesser l'utilisation. Peut causer de la nausée, de la douleur abdominale, et/ou de la diarrhée.
Source
Official Health Canada record, licence 80067936
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging